ATOWW Projected Dividend Yield
Atossa Therapeutics Inc ( OTCBB : ATOWW )Atossa Therapeutics is a clinical-stage biopharmaceutical company seeking to discover and develop medicines in areas of oncology and infectious diseases, with a focus on breast cancer, other breast conditions and COVID-19. Co.'s drug under development for breast cancer and other breast conditions is Endoxifen which is being developed primarily in two settings. Co.'s two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. 20 YEAR PERFORMANCE RESULTS |
ATOWW Dividend History Detail ATOWW Dividend News ATOWW Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |